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Neutrophils mediate bacterial clearance through
various mechanisms, including the release of mesh-
like DNA structures or neutrophil extracellular traps
(NETs) that capture bacteria. Although neutrophils
are also recruited to sites of viral infection, their role
in antiviral innate immunity is less clear. We show
that systemic administration of virus analogs or
poxvirus infection induces neutrophil recruitment to
the liver microvasculature and the release of NETs
that protect host cells from virus infection. After
systemic intravenous poxvirus challenge, mice
exhibit thrombocytopenia and the recruitment of
both neutrophils and platelets to the liver vascula-
ture. Circulating platelets interact with, roll along,
and adhere to the surface of adherent neutrophils,
forming large, dynamic aggregates. These interac-
tions facilitate the release of NETs within the liver
vasculature that are able to protect host cells from
poxvirus infection. These findings highlight the role
of NETs and early tissue-wide responses in prevent-
ing viral infection.
INTRODUCTION
Although antiviral immunity has classically been studied in terms
of the adaptive arm of the immune system,much evidence exists
to suggest that early stage innate immunity plays an important
role. The innate immune system is comprised of a variety of
different cell types that recognize, and respond to, pathogens
in a nonspecific fashion using a diverse array of pattern-recogni-
tion receptors (PRRs) (Akira, 2011). These PRRs, including Toll-
like receptors (TLRs), NOD-like receptors (NLRs), and RIG-like
receptors (RLRs), do not recognize specific pathogens per se,
but rather, recognize pathogen-associated molecular patterns
(PAMPs) (Akira, 2011). The innate immune system has evolvedCell Host &to express several PRRs specific for viral ligands (TLR3, TLR7,
TLR8, RIG-I, and MDA5) and produce a number of potent, anti-
viral mediators (type I and type II interferons, tumor necrosis
factor a, interleukin-15, and interleukin-18) (McGill et al., 2009;
Christensen and Thomsen, 2009), illustrating the importance of
of the innate immune responses in host viral defense.
A central cell type in the innate immune response to bacterial
pathogens is the neutrophil. Studies aimed at defining the role of
neutrophils in controlling the early stages of viral infections
remain inconclusive. The recruitment of neutrophils to the lungs
and airways of animals infected with influenza results in elevated
levels of proinflammatory cytokines (Perrone et al., 2008; Tate
et al., 2009) and has been shown to play an important role in
limiting viral replication and disease progression during the early
phases of infection. In contrast, others have linked neutrophil
recruitment to increased host cell death and fibrin deposition
within the lungs of influenza-infected mice (Pang and Iwasaki,
2011; Thomas et al., 2009), implying a negative role for these
cells in the host antiviral response.
These studies have focused on classical neutrophil effector
mechanisms (granular contents, reactive oxygen species
[ROS], and cytokine production). Recently, another neutrophil
effector mechanism has been described whereby neutrophils
are able to control microbial infection through the release of de-
condensed chromatin from their nuclei, resulting in the genera-
tion of a mesh-like structure of ‘‘sticky’’ DNA threads (Brinkmann
et al., 2004; Borregaard, 2010). These neutrophil extracellular
traps (NETs) carry a large negative electrostatic charge and are
‘‘decorated’’ with numerous nuclear and granular proteins,
including histones, defensins, and various proteases. Little infor-
mation is available about the role of NETs in the host antiviral
response. While some studies using influenza suggest that
NETs are dispensable in the control of infection, other studies
have demonstrated that the human immunodeficiency virus
(HIV-1) is able to elicit NET production and that incubation of
HIV-1 with NETs results in the neutralization of the virus
(Hemmers et al., 2011; Saitoh et al., 2012). It is important to
note that many of these studies utilized an in vitro approach
and that little is known aboutmechanisms leading toNET release
in vivo.Microbe 13, 169–180, February 13, 2013 ª2013 Elsevier Inc. 169
Figure 1. Intraperitoneal Treatment of Mice with Viral PAMPs or
Systemic Infection with MYXV Results in Neutrophil Recruitment to
the Liver
(Ai andAii) Intravitalmicroscopy of anuntreated liver (Ai) and the liver of amouse
treated with 200 mg poly(I:C) for 8 hr (Aii) (neutrophils labeled with 1.6 mg Alexa
Fluor 647-conjugated anti-Gr-1 [blue]; scale bars represent 50 mm).
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induced by platelets binding to adherent neutrophils in blood
vessels (Clark et al., 2007; McDonald et al., 2012). Platelets, in
addition to their central role in hemostasis, are important compo-
nents of the innate immune response and have been demon-
strated to play a key role in the detection of, and response to,
microbial pathogens via TLRs (Semple and Freedman, 2010; An-
donegui et al., 2005; Pak et al., 2010; Rosenfeld et al., 1985).
Moreover, platelets have been demonstrated to directly modu-
late leukocyte activation, recruitment, and adhesion (Vanicha-
karn et al., 2008; Kornerup et al., 2010; von Hundelshausen
et al., 2009). These immune-modulator functions identify plate-
lets in a key position as potential contributors to the host innate
immune reaction.
The liver represents an important interface between viruses
and host immunity and is often frontline in defense to viruses.
As such, the liver is frequently the target of infection, resulting
in both acute and chronic disease (Protzer et al., 2012). Upon
detection of a bacterial pathogen, the liver is able to rapidly
recruit large numbers of immune cells, including neutrophils
and platelets (McDonald et al., 2008; McDonald et al., 2012; Me-
nezes et al., 2009; Jenne et al., 2011). By contrast, the innate
immune response to viruses in this tissue is less well understood.
This study visualized the early innate immune responses to viral
analogs and viruses in the liver and identified molecular mecha-
nisms of how these responses can protect host from viral
pathogens.
RESULTS
Systemic Delivery of Viral Analogs or Systemic Viral
Infection Induces Neutrophil Recruitment to the Liver
Systemic treatment of mice with a double-stranded RNA
(dsRNA) viral analog, polyinosinic:polycytidylic acid [poly(I:C)],
induced a rapid and profound recruitment of neutrophils to
the liver (Figures 1Ai and 1Aii and Movie S1 available online).
This recruitment was so substantial that 6–8 hr after treatment,
nearly all liver sinusoids contained neutrophils. Surprisingly,
neutrophil recruitment to this viral analog was of a similar
magnitude to that observed after lipopolysaccharide (LPS)(B) Quantification of neutrophils within the liver of untreated mice (UT), 8 hr
after poly(I:C) treatment (pI:C), or 4 hr after 1mg/kg LPS i.v. (LPS).
(C) Quantification of neutrophil recruitment to the liver in response to other viral
analogs; high-molecular-weight poly(I:C), the imidazoquinoline compounds
R848 and R837 (imiquimod).
(Di and Dii) Intravenous injection MYXV-GFP results infection of liver cells
(GFP+ virally infected cells and liver autofluorescence [green]; scale bars
represent 50 mm in Di and 25 mm in Dii).
(Ei) Neutrophil recruitment to the liver microvasculature after MYXV infection
(neutrophils: Alexa Fluor 647-conjugated anti-Gr-1 [blue]; scale bar represents
50 mm).
(Eii) Extended focus image compiled from 21 individual 0.5 mm Z planes
(neutrophils: Alexa Fluor 647-conjugated anti-Gr-1 [blue]; GFP+ virally infected
cells and liver autofluorescence [green]; the scale bar represents 25 mm).
(F) Quantification of neutrophil recruitment to the liver 8 hr after 200 mg poly(I:C)
or 8 hr after i.v. injection of either 5 3 107 PFU or 1 3 107 PFU MYXV.
(G) Quantification of neutrophil recruitment to the liver 8 hr and 48 hr after
200 mg poly(I:C) or 8 hr and 48hr after i.v. injection of 1 3 107 PFU MYXV.
Data are shown as the mean number of neutrophils/field of view (FOV) ± SEM,
n = 3–5 per group; ***p < 0.001. See also Figure S1 and Movie S1.
vier Inc.
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activator. To determine whether this observed neutrophil
recruitment was specific to poly(I:C), we utilized other viral
analogs. Treatment of mice with vaccine-grade, high-molec-
ular-weight poly(I:C) (1.5–8 kb) resulted in a more robust neutro-
phil recruitment to the liver than did conventional poly(I:C)
(approximately 200 bp) (Figure 1C). Furthermore, treatment of
mice with other viral agonists and known ligands for TLR7/8,
R837, and R848 also resulted in significant neutrophil recruit-
ment to the liver (Figure 1C).
To positively identify GR1+ cells as neutrophils and not mono-
cytes, we confirmed costaining with the neutrophil-specific
marker Ly6G (Figures S1A and S1B) and confirmed that the
observed GR1+ cells were negative for the monocyte/macro-
phage marker F4/80 (Figure S1C).
To determine whether a similar innate immune response could
be generated by viral infection of the liver, we exploited a live
virus infection model using a rabbit-specific oncolytic poxvirus,
myxoma virus (MYXV), which has been previously investigated
in mice (Stanford and McFadden, 2007; Stanford et al., 2008).
Systemic infection of mice with MYXV containing an eGFP
expression cassette under the control of a poxvirus early/late
synthetic promoter results in the infection of the liver as evi-
denced by the appearance of GFP-expressing cells 8 hr after
infection (Figures 1Di and 1Dii). Although MYXV is not patho-
genic to mice with an intact interferon system (Wang et al.,
2004) and is rapidly cleared from the animal within 24 hr (France
et al., 2011), systemic infection with live MYXV results in neutro-
phil recruitment to the liver in much the same way as does treat-
ment with poly(I:C) (Figures 1Ei and 1Eii and Movie S1). Interest-
ingly, neutrophil recruitment appears to occur throughout the
liver microvasculature, with many of the neutrophils adherent
to sites located away from infected cells (Figure 1Eii). Quantifica-
tion of the number of neutrophils present in the liver in response
to MYXV infection demonstrates significant cellular recruitment
(Figure 1F). Moreover, both poly(I:C), and virus-induced neutro-
phil recruitment to the liver are transient, with cell numbers re-
turning to baseline by 48 hr (Figure 1G). These findings confirm
the ability of a live, systemic viral infection to replicate the obser-
vations made with viral analogs.
Flow cytometric analysis of neutrophils within the liver reveals
increased CD11b expression, indicating that these cells are acti-
vated after poly(I:C) treatment or viral infection (Figure 2A). Intra-
vital microscopic observation of these neutrophils allows for
a better understanding of their behavior. After treatment with
poly(I:C) or infection with MYXV, neutrophil crawling velocity is
significantly reduced (Figure 2B), similar to treatment with LPS
(Menezes et al., 2009). Furthermore, after viral challenge, neutro-
phils acquire an elongated morphology, appearing to flatten out
and extend along the sinusoidal walls (Figure 2Ci versus Figures
2Cii and 2Ciii). A significant increase in neutrophil length after
viral challenge was noted (Figure 2D). Further analysis of the vir-
ally induced neutrophil behavior identifies a significant increase
in percentage of neutrophils with a pirouetting or probing
behavior (Figure 2E). These cells actively extend pseudopods,
appearing to scan and probe the walls of the liver sinusoids,
but do not displace, instead remaining firmly affixed to a single
location within the microvasculature (Figures 2Fi–2Fiii and
Movie S2).Cell Host &Role of TLR3 and Kupffer Cells in Poly(I:C)- and MYXV-
Induced Neutrophil Recruitment
As neutrophils do not express TLR3, the principle receptor for
exogenous dsRNA, we sought to determine how neutrophils
were activated by poly(I:C). Kupffer cells express TLR3, reside
in the liver, and are positioned perfectly (inside blood vessels)
to detect vascular pathogens (Figure 3Ai). Kupffer cell depletion
with clodronate liposomes (Figure 3Aii) followed by poly(I:C)
challenge resulted in a small, but significant, reduction in
neutrophil recruitment to the liver (Figure 3B). Poly(I:C) chal-
lenge of mice deficient for TLR3 also resulted in a small but
significant reduction in neutrophil recruitment. Surprisingly,
Kupffer cell depletion in TLR3-deficient mice resulted in
a complete inability to recruit neutrophils to the liver after
poly(I:C) challenge. These findings suggest two distinct host
response pathways, one involving Kupffer cells and one
involving TLR3.
MYXV appears to infect a mixed population of liver cells,
including both F4/80+ and F4/80– intravascular cells (Figures
S2Ai–S2Aiii). Although depletion of the F4/80+ Kupffer cells
results in significantly fewer virally infected liver cells (Figures
S2Bi, S2Bii, and S2C), infection of the liver does still occur.
Treatment of mice with CLL prior to infection resulted in the
complete absence of neutrophil recruitment to the liver (Fig-
ure 3B). This finding was surprising given that virally infected
cells were still present in the liver and indicate that Kupffer
cells were entirely responsible for the initiation of the inflam-
matory response to MYXV. In contrast, MYXV-induced
neutrophil recruitment was entirely independent of TLR3
(Figure 3B).
Aside from TLR3, two additional cytoplasmic dsRNA recep-
tors have been identified, MDA-5 and RIG-I (Gitlin et al., 2006;
Yoneyama et al., 2004), both of which share a common signaling
adaptor molecule, MAVS (Tang and Wang, 2009; Takeuchi and
Akira, 2008). Deficiency in either MDA-5 or MAVS had no effect
on the number of liver neutrophils after poly(I:C) challenge (Fig-
ure 3C), and deficiency in MAVS had only a minor effect on
MYXV-induced neutrophil recruitment.
Neutrophil Recruitment in Response to Viral Challenge
Is Largely Mediated by CD11b
Two separate and dominant adhesion mechanisms have been
identified in the liver: CD44/SHAP/hyaluronan (HA) in bacterial
infection models (McDonald et al., 2008) and CD18-mediated
adhesion in sterile inflammation (McDonald et al., 2010).
SHAP is secreted as a soluble molecule that, upon covalent
association with HA, increases the binding affinity of HA and
CD44 (Zhuo et al., 2006; de la Motte et al., 2003). Intravital
microscopy revealed substantial SHAP deposition within the
liver microvasculature after treatment with the viral analog
(Figures 4Ai and 4Aii). Quantification of this SHAP staining in
untreated and treated mice demonstrates a significant increase
in SHAP deposition 8 hr after poly(I:C) challenge (Figure 4B).
Surprisingly, despite increased deposition of SHAP and the
previously identified role for CD44 and HA in poly(I:C)-induced
leukocyte adhesion to mucosal smooth muscle cells (de la
Motte et al., 2003), blockade of CD44 resulted in only a minor
inhibition of neutrophil recruitment after poly(I:C) challenge
(Figure 4C).Microbe 13, 169–180, February 13, 2013 ª2013 Elsevier Inc. 171
Figure 2. Systemic Viral Challenge Results
in Neutrophil Activation
(A) Increased CD11b expression on liver neutro-
phils after treatment with poly(I:C) or MYXV
infection [open blue, UT; open red, poly(I:C); open
dashed green, MYXV; filled gray, MYXV + isotype]
(gated on size, side scatter, and GR1+, represen-
tative of two individual experiments).
(B) Average velocity of all neutrophils present in
a FOV for aminimumof 30 s (data are shown as the
mean velocity ± SEM).
(Ci–Ciii) Morphology of neutrophils within the liver
of an untreated mouse (Ci), 8 hr after poly(I:C)
treatment (Cii), and 8 hr after MYXV infection (Ciii)
(scale bars represent 25 mm). Cells with flattened
or elongated morphology are indicated by arrows.
(D) Neutrophil length within the livers of untreated
mice, mice treated with poly(I:C), and mice in-
fected with MYXV (data are shown as the mean
neutrophil length ± SEM).
(E) Neutrophil behavior within the livers of un-
treated, poly(I:C)-treated, andMYXV-infectedmice
(stationary, cells do not move for >5 min; crawling,
cells present in FOV for >30 s and displace >1 cell
diameter within 5 min; pirouetting/probing, cells
are observed to deform [extend pseudopods,
appearing to scan the vessel walls] but do not
displace from their initial position). Data are shown
as the mean percentage of neutrophils ± SEM.
(Fi–Fiii) Time-lapse images of a neutrophil in the
liver of a poly(I:C)-treated mouse illustrating
a probing/pirouetting behavior (time in seconds as
indicated; arrow denotes extension and subse-
quent retraction of a large pseudopod; the scale
bar represents 25 mm). Length, velocity, and
behavior were measured for >130 cells per group,
nR 4 animals per group.
***p<0.001, **p<0.01, *p<0.05.SeealsoMovieS2.
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(CD11b), in an effort to identify the principle adhesion molecules
in poly(I:C)-mediated neutrophil recruitment to the liver. Treat-
ment of mice with blocking antibodies against CD11a had no
effect on poly(I:C)-mediated neutrophil recruitment to the liver.
In contrast, blockade of CD11b resulted in a significant reduction
in the number of neutrophils present in the liver after either
poly(I:C) treatment or MYXV infection (Figure 4D). Blockade of172 Cell Host & Microbe 13, 169–180, February 13, 2013 ª2013 Elsevier Inc.both CD44 and CD11b did not demon-
strate an additive effect (Figure 4D).




After systemic poly(I:C) challenge, mice
were found to be thrombocytopenic (Fig-
ure 5A). Intravital microscopic analysis of
the liver after poly(I:C) treatment or MYXV
infection revealed massive platelet accu-
mulationwithin the liver sinusoids (Figures
5Bi–5Biii and Movie S3). Through the use
of intravital microscopy, we observedthat many of these platelets appeared to form large aggregates
within the liver sinusoids. Quantification of the number of aggre-
gates of increasing size demonstrated a 3-fold increase in small
platelet aggregates (10 mm2) and more than a 10-fold increase in
the number of large platelet aggregates (50 mm2) after either
poly(I:C) treatment or viral infection (Figures 5C and 5D).
Deficiency in the platelet adhesion molecule Gp1b or blocking
antibodies against von Willebrand factor (vWf), an important
Figure 3. Poly(I:C)-Induced Neutrophil Recruitment to the Liver Is
Partly Dependent on both Kupffer Cells and TLR3, whereas MYXV-
Induced Neutrophil Recruitment Is TLR3 Independent
(Ai and Aii) Intravital microscopy of Kupffer cell distribution in the liver of
untreated (Ai) and CLL-treatedmice (Aii) (Kupffer cells, PE-conjugated anti-F4/
80 [red]; vessels, Alexa Fluor 647-conjugated anti-CD31; scale bars represent
50 mm).
(B) Depletion of Kupffer cells or deficiency in TLR3 results in significant inhi-
bition of neutrophil recruitment to the liver after poly(I:C) treatment. Depletion
of Kupffer cells in TLR3-deficient mice completely blocked poly(I:C)-induced
neutrophil recruitment. Neutrophil recruitment to the liver in response toMYXV
infection is dependent on Kupffer cells and is independent of TLR3.
(C) Neutrophil recruitment in response to MYXV infection is partly dependent
on the signaling adaptor molecule, MAVS. Deficiency in either MAVS or the
cytoplasmic dsRNA receptor, MDA5, alone fails to inhibit poly(I:C)-induced
neutrophil recruitment to the liver.
Data are shown as the mean number of neutrophils/FOV ± SEM; n R 3 per
group; ***p < 0.001. See also Figure S2.
Figure 4. MYXV Infection-Induced Neutrophil Recruitment to the
Liver Is Dependent on CD11b
(Ai and Aii) Intravital microscopy analysis of SHAP deposition (red) within liver
sinusoids of an untreated (Ai) and a poly(I:C)-treated mouse (Aii) (scale bars
represent 50 mm).
(B) Quantification of SHAP staining in untreated and poly(I:C)-treated mice
(minimum of five FOV in each of three mice per group, mean area of staining ±
SEM).
(C) Antibody-mediated blockade of CD44 results in a small, but significant,
inhibition of poly(I:C)-induced neutrophil recruitment to the liver.
(D) Blockade CD11b, but not CD11a, results in significant inhibition of
poly(I:C)-induced neutrophil recruitment to the liver. MYXV-induced neutrophil
recruitment is dependent on CD11b.
Data are shown as the mean number of neutrophils/FOV ± SEM; n R 3 per
group (anti-CD11a pI:C, n = 2); ***p < 0.001, **p < 0.01.
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Intravascular Immunity Blocks Viral Infectionligand for Gp1b, did not inhibit platelet recruitment to the liver
after poly(I:C) treatment (data not shown). In contrast, either
a deficiency in CD41 (integrin aIIb) or blockade of CD11b signifi-
cantly inhibited platelet recruitment to the liver and completely
blocked the generation of large aggregates after poly(I:C) treat-Cell Host &ment (Figure 5C). Similarly, deficiency in CD41 was also able to
attenuate platelet aggregation after MYXV infection, albeit to
a lesser extent than was observed after poly(I:C) (Figure 5D).
Interestingly, depletion of neutrophils (anti-GR1) prior to viral
analog challenge also significantly inhibited platelet aggregation
(Figure 5C), suggesting that platelet-neutrophil interactions were
also essential for the generation of large platelet aggregates.
Similar to what was observed with neutrophil recruitment,Microbe 13, 169–180, February 13, 2013 ª2013 Elsevier Inc. 173
Figure 5. Treatment with Viral Ligands or Systemic Viral Infection
Induces Thrombocytopenia and Platelet Aggregation within the
Liver
(A) Reduction in circulating platelets in mice 8 hr after treatment with poly(I:C)
(mean number of platelets/liter ± SEM).
(Bi–Biii) Intravital visualization of platelet aggregation within the livers of
virally challenged mice. Platelets in an untreated liver (Bi) do not aggregated
and appear as individual platelets located within the liver vasculature. After
poly(I:C) treatment (Bii) or infection with MYXV (Biii), platelets form large,
dynamic aggregates in the liver vasculature (neutrophils, Alexa Fluor 647-
Cell Host & Microbe
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174 Cell Host & Microbe 13, 169–180, February 13, 2013 ª2013 Elseplatelet aggregation was a transient event with values returning
to baseline by 48 hr after challenge (Figures 5C and 5D).
Characterization of Platelet-Neutrophil Interactions
Induced by Viral Challenge
We utilized CD41-YFPki/+ mice as previously described (Jenne
et al., 2011) to observe individual platelet-neutrophil interactions.
In these mice, only a fraction of platelets express YFP (Zhang
et al., 2007), and, as such, it is possible to observe individual
platelet-neutrophil interactions even at sites of massive platelet
aggregation (Figures 6Ai and 6Aii). Using these mice, we could
demonstrate a significant increase in the number of YFP+ plate-
lets bound by each neutrophil (Figure 6B). Furthermore, we
observed a significant decrease in the fraction of neutrophils
that had no bound YFP+ platelets and a corresponding signifi-
cant increase in the fraction of neutrophils that had bound three
or more YFP+ platelets (Figure 6C). These experiments clearly
demonstrate, without the use of antibody to label platelets, an
increased association between platelets and neutrophils within
the liver microvasculature after challenge with systemic dsRNA.
We also utilized the intravital spinning-disk confocal micro-
scope to optically section the liver, creating z stacks, and allow-
ing for the generation of extended focus images and videos. In
these extended focus images, we can observe the presence of
individual platelets, free from neutrophils, throughout the liver
vasculature in untreated mice (Figure 6Di). In contrast, platelets
in poly(I:C)-treated mice or MYXV-infected mice form large
aggregates that were located on the surface of, and around,
the many adherent neutrophils (Figures 6Ei and 6Fi). By gener-
ating 3D models from these z stacks using the Volocity software
package, we are able to better visualize these associations from
a number of different perspectives (Figures 6Dii, 6Eii, and 6Fii).
Models of individual neutrophils from untreated mice reveal
few platelet-neutrophil associations (Figures 6Dii–6Div). In
contrast, platelets in poly(I:C)-treated or MYXV-infected mice
made intimate contact with adherent neutrophils, forming aggre-
gates that wrapped around large portions of the neutrophil
surface (Figures 6Eii–6Eiv and 6Fii–6Fiv). Further examination
of thesemodels in the form of 4D imaging revealed these platelet
aggregates to be highly dynamic structures. Platelets in
poly(I:C)-treated mice interacted with the surface of adherent
neutrophils, often flowing across the neutrophil, forming largeconjugated anti-Gr-1 (blue); platelets, 1.6 mg PE-conjugated anti-CD49b [red];
scale bars represent 50 mm).
(C) Accumulation of large platelet aggregates within the liver of poly(I:C)-
treated mice is dependent on CD41 and CD11b. Quantification of platelet
aggregates of the indicated sizes in untreatedmice, 8 hr poly(I:C)-treatedmice,
8 hr poly(I:C)-treated CD41-deficient mice, 8 hr poly(I:C)-treated mice that had
received a CD11b-blocking antibody, 8 hr poly(I:C)-treated mice that had been
previously depleted of neutrophils (anti-GR1 pI:C), and 48 hr poly(I:C)-treated
mice is shown.
(D) Accumulation of large platelet aggregates within the liver of mice after
infection with MYXV. Quantification of platelet aggregates of indicated sizes in
untreated, 8h MYXV-infected, 8h MYXV-infected CD41-deficient, and 48h
MYXV-infected mice is shown.
Data shown as the mean number aggregates of the indicated sizes/FOV ±
SEM nR 3 per group; * versus UT, y versus B6 pI:C, z versus B6 MYXV; ***p <
0.001, **p < 0.01, *p < 0.05.
See also Movie S3.
vier Inc.
Figure 6. Platelets Interact with, and Aggregate around, Neutrophils
in the Liver of Virally Challenged Mice
(Ai and Aii) Intravital microscopy of livers from untreated (Ai) and poly(I:C)-
treated (Aii) CD41-YFP mice (neutrophils, Alexa Fluor 647-conjugated anti-Gr-
Cell Host & Microbe
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Cell Host &aggregates on the downstream surface of the cell before
releasing and re-entering the circulation (Movie S4). These
experiments further support the observation that the surface of
adherent neutrophils provides an ideal platform to support
platelet recruitment and adhesion (Carvalho-Tavares et al.,
2000).
Viral Infection Induces the Release of NETs within the
Liver Vasculature
LPS-activated platelets can bind adherent neutrophils under
flow conditions and induce the production of NETs in an
in vitro model (Clark et al., 2007). Using intravital microscopy,
we looked for the presence of NET-associated proteins within
the liver vasculature after either poly(I:C) challenge or MYXV
infection. In untreated mice, extracellular histone (Figure 7Ai)
and neutrophil elastase (Figure 7Aii) were nearly undetectable.
In contrast, clear staining of these molecules was observed after
either poly(I:C) or MYXV challenge (Figures 7Bi, 7Bii, 7Ci, and
7Cii). Overlay of histone and elastase staining revealed substan-
tial colocalization in poly(I:C) and virally infected mice (Figures
7Biii and 7Ciii) but little staining in untreated mice (Figure 7Aiii).
The addition of the green fluorescent channel localizes these
punctate NET structures exclusively along the walls of liver
vasculature (Figures 7Aiv, 7Av, 7Biv, 7Bv, 7Civ, and 7Cv). Inter-
estingly, these structures are located throughout the liver vascu-
lature and do not appear to be specifically focused around virally
infected cells. Quantification of the total area of elastase staining
revealed a significant increase after dsRNA challenge or viral
infection (Figure 7D). Treatment of CD41-deficient mice with
poly(I:C) failed to induce NET formation, indicating that platelet
accumulation on the adherent neutrophils within the liver was
essential for NET production (Figure 7D).
NETs Protect Host Cells from MYXV Challenge
Although MYXV is a replication-competent virus, it is quickly
recognized and cleared by the innate immune response in in-
fected mice (Wang et al., 2004). As such, it is problematic to
use this model to study the role of NETs in limiting viral infection
and dissemination. To overcome this limitation, we first treated1 [blue]; YFP+ platelets and liver autofluorescence [green]; scale bars repre-
sent 25 mm).
(B) Average number of YFP+ platelets bound (associated for R30 s) per
neutrophil in untreated and poly(I:C)-treated mice (mean number of YFP+
platelets/neutrophil ± SEM).
(C) Percentage of neutrophils with either zero (0) or three or more (3+) bound
platelets in untreated and poly(I:C)-treated mice (mean percentage of
neutrophils ± SEM).
(Di–Fiv) Extended focus images (Di, Ei, and Fi) and 3D opacity models (Dii–Div,
Eii–Eiv, and Fii–Fiv) rendered from a series of 30 z planes from untreated (Di–
Div), poly(I:C)-treated (Ei–Eiv), and MYXV-infected (Fi–Fiv) mice illustrating
platelet neutrophil associations within the liver of poly(I:C)-treated and MYXV
infected mice (neutrophils, Alexa Fluor 647-conjugated anti-Gr-1 [blue];
platelets, PE-conjugated anti-CD49b [red]; GFP+ virus infected cells [green];
scale bars represent 25 mm, grid 25.7 mm). Neutrophil-platelet aggregates from
untreated (Diii and Diiv), poly(I:C)-treated (Eiii and Eiv), and MYXV-infected (Fii
and Fiv) mice illustrating the intimate association between platelets and
neutrophils in poly(I:C)-treated and virally infected livers are shown.
Models were extracted (as indicated by the black arrows) and enlarged from
(Dii), (Eii), and (Fii).
nR 3 per group; ***p < 0.001. See also Movie S4.
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Figure 7. Poly(I:C) Induces the Release of Neutrophil Extracellular Traps, and These Structures Protect Host Cells from Viral Infection
(Ai–Cv) Intravital visualization of NET deposition in the liver vasculature of untreated (Ai–Av), poly(I:C)-treated (Bi–Bv), and MYXV-infected (Ci–Cv) mice. Staining
for extracellular histone (Ai, Bi, and Ci) and neutrophil elastase (Aii, Bii, and Cii) illustrates clear deposition of these hallmark molecules of NETs in the liver after
poly(I:C) or viral treatment. Overlay of histone and elastase staining is shown (Aiii, Biii, and Ciii). Addition of a third channel overlay (Aiv, Biv, and CiV) (liver
autofluorescence [green] and GFP+ virally infected cells) localizes this staining along the walls of the liver sinusoids (scale bars represent 25 mm). A higher
magnification of the indicated areas is shown (Av, Bv, and Cv) (scale bars represent 10 mm).
(D) Quantification of extracellular neutrophil elastase within the livers of untreated, poly(I:C)-treated, poly(I:C)-treated CD41-deficient, and MYXV-infected mice
(virus) (mean area of staining per 203 FOV ± SEM).
(E) Quantification of infected host cells (GFP+) in mice infected with 1 3 107 PFU MYXV-GFP. Mice received no pretreatment (Virus Alone), 1 mg/kg LPS i.v 4 hr
prior to viral infection (NETs + virus), or 1mg/kg LPS together with 2,000 U DNase I i.v 4 hr prior to viral infection (NETs + DNase + virus) (normalizedmean number
of GFP+ cells/FOV ± SEM).
Elastase staining was measured in at least six FOV/mouse, n = 3–4 animals per group; GFP+ cells were measured in eight FOV/mouse, n = 4 animals per group;
*p < 0.05.
Cell Host & Microbe
Intravascular Immunity Blocks Viral Infectionmice with LPS to induce the formation of NETs prior to intrave-
nous (i.v.) injection of live MYXV. LPS, rather than poly(I:C), was
used to induce NETs as it does not specifically prime antiviral
response. We then studied the ability of these extracellular
DNA structures to protect the mouse liver cells from fresh
MYXV infection. In comparison to a mouse receiving MYXV
alone, pretreatment of mice with LPS significantly, and dramat-
ically, reduced the number of infected liver cells after i.v. admin-
istration of 1 3 107 plaque forming units (PFU) live MYXV-GFP176 Cell Host & Microbe 13, 169–180, February 13, 2013 ª2013 Else(Figure 7E). To ensure that this protection was the result of
NETs and not due to some other aspect of LPS pretreatment,
we also treated another group of LPS-treated mice with i.v.
DNase to disrupt extracellular DNA (McDonald et al., 2012). In
these mice, there was a loss of protection and viral infection
rates approached levels observed in mice receiving virus alone
(Figure 7E). These studies clearly and definitively demonstrate
the ability of NETs to protect host cells from viral infection
in vivo.vier Inc.
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The host response to virus is often thought to be dominated by
lymphocytes, natural killer cells, and antigen-presenting cells;
however, clear evidence of a role for early innate responses
and acute inflammation in the host response to viral infection
has begun to emerge. In this study, we demonstrate rapid and
profound recruitment of neutrophils to the mouse liver after viral
challenge. Although both bacterial and viral challenges result in
comparable neutrophil recruitment to the liver, they appear to
do so using very different mechanisms. Whereas neutrophil
recruitment in response to bacterial ligands is entirely depen-
dent on CD44 binding to SHAP-modified HA (McDonald et al.,
2008), recruitment in response to the viral ligands is largely
dependent on the integrin CD11b. Importantly, a number of
ligands for CD11b, including ICAM-1 and ICAM-2, are constitu-
tively expressed within the liver vasculature (Menezes et al.,
2009). Moreover, we observed elevated CD11b levels on
neutrophils after viral challenge, providing further support for
a central role for this molecule in neutrophil recruitment to the
liver.
This innate immune response was not restricted to challenge
with a specific viral ligand but rather was observed to occur in
response to systemic challenge with a number of viral analogs
[poly(I:C), R837, and R848], as well as live viral challenge with
a poxvirus, MYXV. Although MYXV is not a mouse pathogen, it
is able to initiate infection of primary mouse cells and elicit
a host inflammatory response, but the infection is progressively
terminated by the type I interferon response pathway (Wang
et al., 2004). The host innate response to this virus is of particular
importance given the emerging role of this virus and other viruses
as oncolytic virotherapy treatments for human tumors (Stanford
and McFadden, 2007; Breitbach et al., 2011). Significantly, two
distinct oncolytic poxviruses, vaccinia and MYXV, have been
delivered by systemic intravenous administration to treat liver
cancer and metastatic melanoma in humans. Although
nonpathogenic and unable to replicate in normal host tissues,
a number of tumors have been shown to be highly permissive
to these oncolytic viruses. The safe, and effective, use of these
oncolytic viruses in humans will depend critically on our under-
standing of the interactions between the host innate immune
response and viral infection and how the oncolytic viruses are
recognized and cleared from normal tissues.
Clinical data from patients critically ill with influenza suggest
a linkage between severe viral infection and dysfunction of the
innate immune response, including excessive inflammatory infil-
trates in organs such as lungs and liver, neutropenia (reduced
number of circulating neutrophils), and thrombocytopenia
(reduced number of circulating platelets). Although some
evidence supports the model that influenza infection can
increase bacterial adherence to airway epithelial cells (Hament
et al., 1999), a growing number of studies suggest severe influ-
enza infection may cause dysregulation of the host innate
immune system (as reviewed in Hussell and Williams, 2004).
Our data suggest that neutrophil recruitment to a site of viral
infection is actually part of a protective strategy, orchestrated
by the innate immune system, with the intention to capture the
viral particles via the generation of NETs, thereby protecting
host cells from further viral dissemination.Cell Host &NETs, and their associated proteins, have been demonstrated
to have an antimicrobial effect and are thought to help contain
infections (Clark et al., 2007; Brinkmann et al., 2004). Previously,
little information was available regarding the role of NETs in the
host response to virus, although a couple of lines of evidence
have suggested these structures might in fact have some ability
to inhibit viral infection. One protein found associated with NETs,
a-defensin, has been shown to directly inhibit influenza replica-
tion and protein synthesis (Doss et al., 2009; Schoen et al.,
1997). Furthermore, viral fusion has been shown to be blocked
when viruses are bound by molecules carrying a strong negative
electrostatic charge as is present on DNA (Schoen et al., 1997).
More recently, in vitro studies have indicated that HIV-1 can elicit
the formation of, and is neutralized by, NETs (Saitoh et al., 2012).
We have shown that NETs are effective in protecting host cells
from infection by circulating viral particles using an in vivomouse
model. Our studies clearly demonstrate that NETs within the liver
microvasculature significantly reduced the number of infected
host cells, and this protection is absolutely dependent on the
presence of extracellular DNA within the vasculature. Disruption
of these NETs with i.v. DNase abrogates the observed
protection.
It should be noted that neutrophils are not the only cell type
involved in NET formation. Our findings demonstrate a require-
ment for platelet aggregation on adherent neutrophils in the
generation of NETs. We observe massive platelet sequestration
within the liver after viral challenge, and, furthermore, if we
prevent this aggregation (such as in CD41-deficient mice),
NETs fail to form. In fact, platelets play a critical functional role
in the host viral response. Clinical data obtained from the 2009
pandemic H1N1 outbreak indicate that many of the patients
requiring intensive-care-unit admission were reported to be
thrombocytopenic (Kumar et al., 2009; Venkata et al., 2010).
This observation was even more pronounced in patients who
succumbed to the infection, suggesting that during severe viral
infection, platelet loss or, more likely, platelet sequestration
within organs such as the liver may contribute to the massive
systemic inflammatory response seen within these patients.
Although the dissolution of NETs, through the administration
of DNase, led to increased dissemination of the virus as
measured by the total number of GFP+ infected cells, it is also
possible that NETsmay actually contribute to viral pathogenesis.
A number of studies have indicated that NETs can cause collat-
eral host cell damage (partly due to the high concentration of
proteases associated with these structures) (Medina, 2009;
Clark et al., 2007; McDonald et al., 2012). As such, it is likely
the balance between reduced host cell infection rates and this
potential for collateral damage that determines whether NETs
play a beneficial role in a given viral infection. With our identifica-
tion of key molecules mediating platelet-neutrophil interactions,
including CD11b and CD41, an opportunity might exist to thera-
peutically intervene to reduce or modulate the massive inflam-
matory response, thereby limiting potential collateral damage.
We demonstrate that viral infection induces the production,
and deposition of NETs within the liver microvasculature. Most
importantly, we also demonstrate that NETs play an important
role in early innate antiviral immunity in vivo, protecting host cells
from disseminating viral infection. Collectively, these results
highlight a dynamic and coordinated innate immune responseMicrobe 13, 169–180, February 13, 2013 ª2013 Elsevier Inc. 177
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Intravascular Immunity Blocks Viral Infectionto systemic viral challenge that involves the recruitment of
neutrophils and platelets to the liver, the production of intravas-
cular NETs, and the protection of host cells from viral infection.
From these findings, it is clear that the innate immune system




All experiments involving animals were approved by the University of Calgary
Animal Care Committee (protocol numbers MO8131 and MO7098) and
conform to the guidelines established by the Canadian Council for Animal
Care. For all experiments, mice were anesthetized by intraperitoneal (i.p.)
injection of 200 mg/kg ketamine (Bayer Animal Health, Toronto, Canada)
and 10 mg/kg xylazine (Bimeda-MTC, Cambridge, Canada).
Mice
Wild-type C57BL/6J mice were purchased from The Jackson Laboratory (Bar
Harbor, ME). CD41-YFP ki/+ mice were a generous gift from Dr. Kelly
McNagny, University of British Columbia, Vancouver, Canada. The Mda5/
and MAVS-deficient (IPS-1/) mice were a generous gift from Dr. Russell
Vance, University of California, Berkeley. All colonies were maintained in
specific-pathogen-free facilities at the University of Calgary. At the time of
use, animals were between 7 and 10 weeks of age and weighed 20–30 g.
Antibodies and Treatments
Phycoerythrin (PE)-conjugated Armenian hamster anti-mouse CD49b (clone
HMa2), unconjugaed rat anti-mouse CD11a (M17/4), and unconjugated and
PerCP-Cy5.5-conjugated rat anti-mouse CD11b (clone M1/70) antibodies
were purchased fromBDBiosciences PharMingen (San Diego, CA). PE-conju-
gated rat anti-mouse F4/80 (clone BM8), unconjugated rat anti-mouse
PECAM-1 (clone 390), unconjugated, Alexa Fluor 647-conjugated, and FITC-
conjugated rat anti-mouse GR1 (clone RB6-8C5) antibodies were purchased
from eBioscience (San Diego, CA). PE-conjugated anti-mouse Ly6G (clone
1A8) was purchased from Biolegend (San Diego, CA). Unconjugated rat
anti-mouse CD44 antibody (KM81) was purchased from Cedarlane Labs
(Burlington, Ontario, Canada). Goat anti-mouse histone H2Ax (M20), goat
anti-mouse neutrophil elastase (M18), and goat anti-mouse SHAP antibodies
[ITI-H1 (K16) and ITI-H2 (K17)] were purchased fromSanta Cruz Biotechnology
(Santa Cruz, CA). Sytox green DNA dye was purchased from Invitrogen
(Eugene, Oregon).
For intravital microscopy, PECAM-1 and neutrophil elastase antibodies
were conjugated to Alexa Fluor 647 and SHAP and Histone H2Ax antibodies
were conjugated to Alexa Fluor 555 with protein labeling kits as per the manu-
facturer’s instructions (Invitrogen, Eugene, OR).
Poly(I:C) and highly purified LPS (Escherichia coli O111:B4) were purchased
from Calbiochem (EMD Sciences, San Diego, CA). Vaccine-grade, high-
molecular-weight poly(I:C), imiquimod (R837), and resiquimod (R848) were
purchased from Invivogen (San Diego, CA). Animals received an i.p. injection
of one of either 200 mg poly(I:C), 200 mg high-molecular-weight poly(I:C),
20 mg R837, or 100 mg R848 8h prior to intravital microscopic visualization.
Alternatively, some animals received an i.v. injection of 1 mg/kg LPS 4 hr prior
to intravital microscopy.
In vivo blockade of adhesion molecules was achieved by i.v. administration
of 40 mg unconjugated anti-CD11a, 30 mg unconjugated anti-CD11b, or 20 mg
unconjugated anti-CD44 mAb, based on previous dose-response studies,
20 min prior to poly(I:C) treatement. Neutrophil depletion was performed by
i.p. injection of 200 mg unconjugated GR-1 24 hr prior to poly(I:C) treatment.
Kupffer cell depletion was achieved by i.v. injection of 200 ml clodronate lipo-
somes 30 hr prior to poly(I:C) treatment as previously described (Lee et al.,
2010; Van Rooijen and Sanders, 1994). For in vivo disruption of NETs, mice
received 2,000 U i.v. cell culture grade DNase I (Roche, Mississauga, Canada)
4 hr prior to viral infection.
Viral Culture and Infection
Please refer to the Supplemental Experimental Procedures.178 Cell Host & Microbe 13, 169–180, February 13, 2013 ª2013 ElseSpinning-Disk Confocal Intravital Microscopy
Liver microscopy was performed with an Olympus IX81 inverted microscope
(Olympus, Center Valley, PA), equipped with an Olympus focus drive and
a motorized stage (Applied Scientific Instrumentation, Eugene, OR). The
microscope is fitted with a motorized objective turret equipped with
UPLANSAPO 103/0.40 and UPLANSAPO 203/0.75 objective lenses and is
mounted on an antivibration optical table (Newport, Irvine, CA). This micro-
scope is coupled to a confocal light path (WaveFx; Quorum Technologies,
Guelph, Canada) based on a modified Yokogawa CSUX1-M1L-E head (Yoko-
gawa Electric Corporation, Tokyo, Japan).
Each of 491, 561, and 643 nm excitation laser wavelengths (Cobolt, Stock-
holm, Sweden) were sequentially controlled and merged into a single optic
cable with an LMM5 laser merge module (Spectral Applied Research, Rich-
mond Hill,, Canada). Fluorescence was visualized through one of ET 525/
50M (green channel), FF 593/40 (red channel), or ET 700/75M (far red channel)
band-pass emission filters (Semrock, Rochester, NY) driven by a MAC 6000
Modular Automation Controller (Ludl Electronic Products, Hawthorne, NY)
and detected with a 512 3 512 pixel back-thinned EMCCD camera (C9100-
13, Hamamatsu, Bridgewater, NJ). Volocity Acquisition software (V6.1.1; Im-
provision, Lexington, MA) was used to drive the confocal microscope. Image
acquisition settings varied according to the microscope used and the tissue
visualized. Typical laser power, exposure time, and sensitivity settings were
as follows: green channel (autofluorescence, 80%, 415 ms, 215; CD41-YFP,
75%, 425 ms, 250; MYXV, 60%, 300 ms, 200), red channel [Ly6G (1A8),
60%, 300 ms,140; SHAP, 90%, 150 ms, 210; CD49b, 90%, 150 ms, 210;
F4/80, 90%, 100 ms, 210; histone, 55%, 400 ms,120], far-red channel [GR1
(RB6-8C5), 80%, 300 ms, 200; Elastase, 55%, 400 ms, 135]. Green, red,
and far-red channels were overlaid with the brightest point settings before
images were exported in .tiff or .avi format.
Preparation of the Mouse Liver for Intravital Microscopy
Intravital microscopy of the mouse liver was performed as previously
described (Wong et al., 1997). In brief, mice were anesthetised and the tail
vein cannulated to permit the injection of fluorescently labeled antibodies
and for the maintenance of anesthetic. The body temperature of the mouse
was maintained with an infrared heat lamp. A midline incision followed by
a lateral incision along the costal margin to the midaxillary line was performed
to expose the liver. The mouse was place in a right lateral position, and liga-
ments attaching the liver to the diaphragm and the stomach were cut, thus
allowing the liver to be externalized onto a glass coverslip located on the
inverted microscope stage. Exposed abdominal tissues were covered with
saline-soaked gauze to prevent dehydration. The liver was draped with
a saline-soaked KimWipe to avoid tissue dehydration and to help restrict
movement of the tissue on the slide.
Flow Cytometry
Please refer to the Supplemental Experimental Procedures.
Platelet Counts
Platelet counts were done as previously described (Jenne et al., 2011).
Analysis of NETs Function In Vivo
Mice were placed into one of three treatment groups. One group received no
pretreatment prior to viral infection, one group received 1 mg/kg LPS i.v. 4 hr
prior to viral infection, and the third group received 1 mg/kg LPS and 2,000 U
DNase I i.v. 4 hr prior to viral infection. All mice were infected with 13 107 PFU
MYXV-GFP 10 hr prior to intravital microscopy. So that differences between
infection rates on different experimental days could be accounted for, all
values were normalized to the number of infected cells counted in the virus
alone treatment group. Values are expressed as the normalized number of
GFP+ liver cells per FOV.
Image Processing
Image and video capture, processing, and export have been previously
described (Jenne et al., 2011).
3D Model Generation
Please refer to the Supplemental Experimental Procedures.vier Inc.
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Intravascular Immunity Blocks Viral InfectionMeasurement of Neutrophil Velocity and Length
Neutrophil velocity was measured with the ImageJ software package V1.41
(NIH, http://rsb.info.nih.gov/ij/). Time-lapse videos exported from Volocity
were imported into ImageJ as .mov files. Files were converted to 8 bit gray-
scale, and themovement of cells wasmeasured viamanual tracking. Only cells
present within the FOV forR30 s were tracked. Cell velocity is expressed as
distance (mm) per time (min). Neutrophil length was measured along the
longest axis of each cell present in each FOV with the Volocity software
package.
Semiquantitative Analysis of SHAP, Platelet Aggregates, and
Neutrophil Elastase
Analysis of platelet aggregates has been published previously (Jenne et al.,
2011). For SHAP and neutrophil elastase analysis, snapshots were generated
from intravital videos, and images corresponding to the red fluorescence
channel alone (Alexa Fluor 555-conjugated anti-SHAP) or the blue fluores-
cence channel alone (Alexa Fluor 647-conjugated anti-neutrophil elastase)
were exported as .tif documents. Analysis of the total area of staining was
done with ImageJ. A common minimum brightness threshold was set for all
images to eliminate background autofluorescence, and the resulting images
were converted to binary. Total area corresponding to fluorescent staining
was measured for each FOV and values are expressed as mm2.
Statistical Analysis
Please refer to the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
two figures, and four movies and can be found with this article online at
http://dx.doi.org/10.1016/j.chom.2013.01.005.
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